tyrosine has been researched along with on012380 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bornmann, WG; Daniels, L; Donato, NJ; Meng, F; Peng, Z; Peterson, LF; Quintás-Cardama, A; Roulston, D; Talpaz, M; Wu, J; Ying, Y | 1 |
1 other study(ies) available for tyrosine and on012380
Article | Year |
---|---|
ON012380, a putative BCR-ABL kinase inhibitor with a unique mechanism of action in imatinib-resistant cells.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzene Derivatives; Cells, Cultured; Dasatinib; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Interleukin-3; K562 Cells; Mice; Mutation; Phosphorylation; Piperazines; Precursor Cells, B-Lymphoid; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Tyrosine | 2010 |